1. Home
  2. TRVG vs ABEO Comparison

TRVG vs ABEO Comparison

Compare TRVG & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.77

Market Cap

211.2M

Sector

Technology

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$4.75

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
ABEO
Founded
2005
1974
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.2M
280.2M
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
TRVG
ABEO
Price
$2.77
$4.75
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$4.09
$18.75
AVG Volume (30 Days)
32.9K
1.0M
Earning Date
01-01-0001
07-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.16
EPS
N/A
1.01
Revenue
N/A
$2,998,000.00
Revenue This Year
$15.59
N/A
Revenue Next Year
$8.42
$1,589.77
P/E Ratio
$16.98
$4.55
Revenue Growth
N/A
258.18
52 Week Low
$2.71
$3.93
52 Week High
$5.83
$7.54

Technical Indicators

Market Signals
Indicator
TRVG
ABEO
Relative Strength Index (RSI) 38.54 41.06
Support Level $2.77 $4.53
Resistance Level $2.93 $5.62
Average True Range (ATR) 0.06 0.21
MACD -0.02 -0.03
Stochastic Oscillator 16.00 32.10

Price Performance

Historical Comparison
TRVG
ABEO

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: